Skip to main content
Bulletin of the National Research Centre

Table 10 Assessment of liver glycogen content in alloxan-induced diabetic rats when treated with EMZSB

From: Screening of Manilkara zapota (L) P. Royen stem bark ethanolic extract for in vitro α-glucosidase inhibition, preliminary antidiabetic effects, and improvement of diabetes and its complications in alloxan-induced diabetes in Wistar rats

Groups

Liver glycogen (mg/100 g)

Normal control

18.45 ± 1.06

Diabetic control

11.28 ± 1.15$

Diabetic + Glimepiride

17.58 ± 0.68**

Diabetic + EMZSB 150

13.94 ± 1.36

Diabetic + EMZSB 200

14.34 ± 1.58

Diabetic + EMZSB 250

16. 15 ± 0.84*

  1. Values were presented as mean ± SEM (n = 6); statistics employed was one-way ANOVA followed by Tukey’s multiple comparison test. $p < 0.01 when compared with normal control; *p < 0.05, **p < 0.01 when compared with diabetic control
Back to article page